Approval · Notice of Compliance 17505 · 2015
FLUKIVER: Notice of Compliance 17505
Issued November 24, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17505
- Date
- November 24, 2015
- Company
- Elanco Division Eli Lilly Canada IncGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antihelmintic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUKIVER | 02449293 | Marketed |
Medicinal ingredients
- CLOSANTEL SODIUM 5 PER